Safety and efficacy of Peginterferon (PEG-IFN) alpha 2 a(40 Kda) plus mycofenolatemofetile (MMF) and Peginterferon alpha 2 a plus Ribavirin (RBV) in unresponsive patients with chronic C hepatitis (CHC).

Maurizio Soresi, Giuseppe Montalto, Silvio Tripi, Amedea Caterina Alessandri, Onofrio Vuturo

Research output: Contribution to conferenceOther

Original languageUndefined/Unknown
Pages131-13
Publication statusPublished - 2005

Cite this